Novel preservation solution for alveolar lavage fluid microbial nucleic acid
A technology of alveolar lavage fluid and microorganisms, which is applied in the field of molecular biology, can solve the problems of high difficulty in clinical detection, strict requirements on the delivery time of alveolar lavage fluid and storage conditions, etc., to maintain cell osmotic pressure, avoid cell lysis, The effect of preventing cell lysis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] A new preservation solution for microbial nucleic acid in alveolar lavage fluid, treatment solution I and treatment solution II, wherein treatment solution I includes 6M guanidine hydrochloride buffer solution, 8mM nuclease inhibitor, 5mM metabolic inhibitor, 0.3M alkali metal halide, 10 % glycerol, the balance is water; the treatment liquid II includes 4M alkali metal hydroxide and 0.5% surface active, and the balance is water.
[0020] When in use, equal volumes of the treatment solution I and the treatment solution II are mixed to obtain the novel preservation solution of microbial nucleic acid in the alveolar lavage fluid.
Embodiment 2
[0022] A new type of preservation solution for microbial nucleic acid in alveolar lavage fluid, treatment solution I and treatment solution II, wherein treatment solution I includes 8M guanidine hydrochloride buffer solution, 5mM nuclease inhibitor, 3mM metabolic inhibitor, 0.5M alkali metal halide, 5 % glycerol, the balance is water; the treatment solution II includes 3M alkali metal hydroxide and 0.3% surface active, and the balance is water.
[0023] When in use, equal volumes of the treatment solution I and the treatment solution II are mixed to obtain the novel preservation solution of microbial nucleic acid in the alveolar lavage fluid.
Embodiment 3
[0025] A new type of preservation solution for microbial nucleic acid in alveolar lavage fluid, treatment solution I and treatment solution II, wherein treatment solution I includes 5M guanidine hydrochloride buffer solution, 10mM nuclease inhibitor, 2mM metabolic inhibitor, 0.2M alkali metal halide, 10 % glycerol, the balance is water; the treatment liquid II includes 5M alkali metal hydroxide and 1% surface active, and the balance is water.
[0026] When in use, equal volumes of the treatment solution I and the treatment solution II are mixed to obtain the novel preservation solution of microbial nucleic acid in the alveolar lavage fluid.
[0027] When using the above novel preservation solution for microbial nucleic acid to process and preserve the alveolar lavage fluid, the volume ratio of the alveolar lavage fluid sample to the novel preservation solution for microbial nucleic acid is 1:3.
[0028] In order to verify the effectiveness of the novel preservation solution of...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com